francesca palandri
University of Bologna
Bologna, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
- Frontiers in Oncology
- Cancer Molecular Targets and Therapeutics
- Editorial Board
Type at least 3 characters
669 editors
Shape the future of research in your field
Join the board
Editors
Review Editors
claudia palena
National Cancer Institute (NIH)
Rockville, United States
Review Editor
Cancer Molecular Targets and Therapeutics
vijay pandey
Tsinghua-Berkeley Shenzhen Institute, Tsinghua University
Shenzhen, China
Review Editor
Cancer Molecular Targets and Therapeutics
barbara pardini
Italian Institute for Genomic Medicine (IIGM)
Turin, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
carlos pedraz
Germans Trias i Pujol Health Science Research Institute (IGTP)
Barcelona, Spain
Review Editor
Cancer Molecular Targets and Therapeutics
paola perego
National Cancer Institute Foundation (IRCCS)
Milan, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
giulia pericoli
Bambino Gesù Children's Hospital (IRCCS)
Rome, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
milica pešić
Siniša Stanković Institute for Biological Research, University of Belgrade
Belgrade, Serbia
Review Editor
Cancer Molecular Targets and Therapeutics
elisabeth phillips
University of Otago, Christchurch
Christchurch, New Zealand
Review Editor
Cancer Molecular Targets and Therapeutics
maria aparecida silva pinhal
Federal University of São Paulo
São Paulo, Brazil
Review Editor
Cancer Molecular Targets and Therapeutics
isabel pires
University of Hull
Hull, United Kingdom
Review Editor
Cancer Molecular Targets and Therapeutics
audrey player
Texas Southern University
Houston, United States
Review Editor
Cancer Molecular Targets and Therapeutics
alessandro poli
Axxam (Italy)
Milan, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
panagiotis politis
Biomedical Research Foundation of the Academy of Athens (BRFAA)
Athens, Greece
Review Editor
Cancer Molecular Targets and Therapeutics
giovanni porta
University of Insubria
Varese, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
yolanda prezado
INSERM U1021 Signalisation Normale et Pathologique de l'embryon aux Thérapies Innovantes des Cancers
Orsay, France
Review Editor
Cancer Molecular Targets and Therapeutics